Yabao Pharma, Lilly In Licensing Deal For Diabetes Drug In China
This article was originally published in PharmAsia News
Executive Summary
Yabao Pharmaceutical said it has signed a partnership with Eli Lilly to co-develop the U.S.-based drug maker's diabetes drug already in clinical trials in the U.S.